Mohammad H. Al‐Shaer

Also affiliated with American Association of Colleges of Pharmacy, United Arab Emirates University, AbbVie (United States), University of Florida

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 17 papers. Top paper: “Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study”.

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

Implementation Science Communications(2021)10.1186/s43058-021-00134-9

N/A

0.716DataRank · unranked

12 citations

Andrew D. Rule, Mohammad H. Al‐Shaer, Jason A. Roberts, Mohd H. Abdul‐Aziz, Marc H. Scheetz +6 more

Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study

Clinical Infectious Diseases(2022)10.1093/cid/ciac511

N/A

0.652DataRank · unranked

15 citations

Stellah Mpagama, О. Б. Огарков, Mark R. Conaway, Shahriar Ahmed, С. Н. Жданова +20 more

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Expert Review of Clinical Pharmacology(2017)10.1080/17512433.2017.1366311

N/A

0.621DataRank · unranked

62 citations

Wael A. Alghamdi, Mohammad H. Al‐Shaer, Kelly E. Dooley, Charles A. Peloquin, Omamah Alfarisi

Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing

Tuberculosis(2022)10.1016/j.tube.2022.102246

N/A

0.360DataRank · unranked

10 citations

Margaretha Sariko, Thomas Walongo, Athanasia Maro, Dorcus Estomih Mduma, Jean Gratz +11 more

Effect of HIV infection on plasma exposure to first-line TB drugs and target attainment in children

The International Journal of Tuberculosis and Lung Disease(2023)10.5588/ijtld.23.0184

N/A

0.165DataRank · unranked

2 citations

Sampson Antwi, Nicole Maranchick, A. Dompreh, A. K. Amissah, E. Sly-Moore +15 more

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis

Frontiers in Pharmacology(2022)10.3389/fphar.2022.1048653

N/A

0DataRank · unranked

22 citations

Mohammad H. Al‐Shaer, Alison Smith, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze +6 more

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01174-20

N/A

0DataRank · unranked

44 citations

Mohammad H. Al‐Shaer, Guohua An, Abdullah Alsultan, Maia Kipiani, Ketevan Barbakadze +7 more

Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study

The Lancet Microbe(2022)10.1016/s2666-5247(21)00308-6

N/A

0DataRank · unranked

10 citations

Museveni Justine, Estomih Mduma, Stellah Mpagama, Mohammad H. Al‐Shaer, Charles A. Peloquin +10 more

The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation

International Journal of Antimicrobial Agents(2023)10.1016/j.ijantimicag.2023.106939

N/A

0DataRank · unranked

9 citations

David Benkeser, Maia Kipiani, Nicole Maranchick, Lali Mikiashvili, Ketevan Barbakadze +7 more

Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children

The International Journal of Tuberculosis and Lung Disease(2023)10.5588/ijtld.22.0591

N/A

0DataRank · unranked

5 citations

Haichuan Yang, Charles Martyn‐Dickens, Anthony Enimil, A. K. Amissah, Oluwayemisi Ojewale +12 more

Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkad211

N/A

0DataRank · unranked

5 citations

Jiajun Liu, Mohammad H. Al‐Shaer, Veena Venugopalan, Nicole Maranchick, Charles A. Peloquin +3 more

Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling

Critical Care Explorations(2023)10.1097/cce.0000000000000993

N/A

0DataRank · unranked

2 citations

Roy Williams, Mays J. Mousa, Kaitlin Alexander, Kelly Maguigan, Kayihura Manigaba +6 more

Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review

Journal of Burn Care & Research(2022)10.1093/jbcr/irac099

N/A

0DataRank · unranked

8 citations

Pavel Mazirka, Gena Burch, Charles A. Peloquin, Zachary Drabick, Joshua Carson +1 more

Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment

Journal of the Pediatric Infectious Diseases Society(2020)10.1093/jpids/piaa024

N/A

0DataRank · unranked

21 citations

Daniel Van Aartsen, Sarah Criddle, Prakruti Rao, Isaac Zentner, Museveni Justine +8 more

Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00713-20

N/A

0DataRank · unranked

6 citations

Anne‐Grete Märtson, Wael A. Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed +9 more

Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness

Clinical Infectious Diseases(2021)10.1093/cid/ciab992

N/A

0DataRank · unranked

44 citations

Alison Smith, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze, Shorena Sabanadze +7 more

Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness

Antibiotics(2021)10.3390/antibiotics10060739

N/A

0DataRank · unranked

13 citations

Christopher C. Moore, Amir A. Mbonde, Edwin Nuwagira, Patrick Orikiriza, Dan Nyehangane +12 more